Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
Recent Patents on Anti-Cancer Drug Discovery
|
July 25, 2016
Topoisomerase I and II Inhibitors: A Patent Review
Arshdeep Singh, Navdeep Kaur, Gurpreet Singh, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
June 18, 2015
Purine Analogues as Kinase Inhibitors: A Review
Sahil Sharma, Samir Mehndiratta, Sunil Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 19, 2015
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents
Dinesh Kumar, Kunal Nepali, P M S Bedi, et al.
Future Medicinal Chemistry
|
January 28, 2026
Recent advances in small molecule ATR kinase inhibitors as anticancer agents
Gurpreet Singh, Ram Sharma, Vinod Gautam, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2014
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors
Harbinder Singh, Sahil Sharma, Ritu Ojha, et al.
Journal of Medicinal Chemistry
|
July 5, 2022
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Amandeep Thakur, Chetna Faujdar, Ram Sharma, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
February 5, 2016
Naphthoflavones as Antiproliferative Agents: Design, Synthesis and Biological Evaluation
Dinesh Kumar, Onkar Singh, Kunal Nepali, et al.
Mini Reviews in Medicinal Chemistry
|
February 18, 2022
The Role of Epigenetic Mechanisms in Autoimmune, Neurodegenerative, Cardiovascular, and Imprinting Disorders
Ram Sharma, Sachin Sharma, Amandeep Thakur, et al.
Current Drug Targets
|
November 10, 2023
N-Heterocycle based Degraders (PROTACs) Manifesting Anticancer Efficacy: Recent Advances
Suddhasatwa Banerjee, Sachin Sharma, Amandeep Thakur, et al.
Archiv Der Pharmazie
|
May 1, 2014
4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors
Shiwani Shukla, Dinesh Kumar, Ritu Ojha, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
Recent Patents on Anti-Cancer Drug Discovery
|
July 25, 2016
Topoisomerase I and II Inhibitors: A Patent Review
Arshdeep Singh, Navdeep Kaur, Gurpreet Singh, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
June 18, 2015
Purine Analogues as Kinase Inhibitors: A Review
Sahil Sharma, Samir Mehndiratta, Sunil Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 19, 2015
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents
Dinesh Kumar, Kunal Nepali, P M S Bedi, et al.
Future Medicinal Chemistry
|
January 28, 2026
Recent advances in small molecule ATR kinase inhibitors as anticancer agents
Gurpreet Singh, Ram Sharma, Vinod Gautam, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2014
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors
Harbinder Singh, Sahil Sharma, Ritu Ojha, et al.
Journal of Medicinal Chemistry
|
July 5, 2022
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Amandeep Thakur, Chetna Faujdar, Ram Sharma, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
February 5, 2016
Naphthoflavones as Antiproliferative Agents: Design, Synthesis and Biological Evaluation
Dinesh Kumar, Onkar Singh, Kunal Nepali, et al.
Mini Reviews in Medicinal Chemistry
|
February 18, 2022
The Role of Epigenetic Mechanisms in Autoimmune, Neurodegenerative, Cardiovascular, and Imprinting Disorders
Ram Sharma, Sachin Sharma, Amandeep Thakur, et al.
Current Drug Targets
|
November 10, 2023
N-Heterocycle based Degraders (PROTACs) Manifesting Anticancer Efficacy: Recent Advances
Suddhasatwa Banerjee, Sachin Sharma, Amandeep Thakur, et al.
Archiv Der Pharmazie
|
May 1, 2014
4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors
Shiwani Shukla, Dinesh Kumar, Ritu Ojha, et al.
Page
of 9